| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Renal Insufficiency, Chronic | 10 | 2022 | 160 | 4.170 |
Why?
|
| Kidney Tubules | 9 | 2021 | 28 | 3.290 |
Why?
|
| MicroRNAs | 8 | 2022 | 386 | 3.230 |
Why?
|
| Epithelial Cells | 18 | 2022 | 366 | 3.110 |
Why?
|
| HIV-1 | 20 | 2018 | 678 | 2.950 |
Why?
|
| Kidney Tubules, Proximal | 8 | 2021 | 25 | 2.940 |
Why?
|
| Diabetic Nephropathies | 7 | 2021 | 53 | 2.750 |
Why?
|
| Exosomes | 6 | 2021 | 97 | 2.640 |
Why?
|
| RNA, Messenger | 16 | 2018 | 1152 | 2.640 |
Why?
|
| Inflammation | 12 | 2022 | 577 | 2.230 |
Why?
|
| Cytidine Deaminase | 12 | 2014 | 31 | 2.150 |
Why?
|
| Kidney Failure, Chronic | 6 | 2020 | 231 | 2.060 |
Why?
|
| vif Gene Products, Human Immunodeficiency Virus | 8 | 2016 | 10 | 2.030 |
Why?
|
| Nephritis, Interstitial | 5 | 2018 | 7 | 2.030 |
Why?
|
| Kidney Diseases | 6 | 2020 | 159 | 1.900 |
Why?
|
| Macrophages | 5 | 2021 | 431 | 1.820 |
Why?
|
| Reperfusion Injury | 4 | 2022 | 53 | 1.810 |
Why?
|
| Fibrosis | 10 | 2021 | 146 | 1.620 |
Why?
|
| Biphenyl Compounds | 4 | 2011 | 52 | 1.390 |
Why?
|
| Tetrazoles | 4 | 2011 | 49 | 1.360 |
Why?
|
| Cells, Cultured | 18 | 2022 | 1442 | 1.360 |
Why?
|
| Calcinosis | 2 | 2022 | 56 | 1.270 |
Why?
|
| Renal Dialysis | 4 | 2022 | 119 | 1.250 |
Why?
|
| Uric Acid | 2 | 2020 | 26 | 1.220 |
Why?
|
| Kidney | 10 | 2022 | 322 | 1.210 |
Why?
|
| Humans | 67 | 2022 | 34853 | 1.200 |
Why?
|
| Male | 38 | 2022 | 18870 | 1.200 |
Why?
|
| Transforming Growth Factor beta1 | 3 | 2019 | 91 | 1.180 |
Why?
|
| Podocytes | 4 | 2021 | 33 | 1.180 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 4 | 2011 | 37 | 1.180 |
Why?
|
| Diabetes Mellitus, Experimental | 4 | 2021 | 87 | 1.170 |
Why?
|
| Immediate-Early Proteins | 5 | 2007 | 45 | 1.160 |
Why?
|
| Carrier Proteins | 4 | 2018 | 287 | 1.130 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 5 | 2007 | 89 | 1.120 |
Why?
|
| Signal Transduction | 7 | 2021 | 1802 | 1.100 |
Why?
|
| Nephroblastoma Overexpressed Protein | 2 | 2017 | 3 | 1.090 |
Why?
|
| Receptors, LDL | 3 | 2015 | 30 | 1.070 |
Why?
|
| gag Gene Products, Human Immunodeficiency Virus | 5 | 2015 | 15 | 1.070 |
Why?
|
| Mice | 22 | 2022 | 5668 | 1.060 |
Why?
|
| Cell Line | 17 | 2021 | 1289 | 1.060 |
Why?
|
| Virus Assembly | 8 | 2015 | 38 | 1.030 |
Why?
|
| Macrophage Activation | 3 | 2021 | 52 | 1.030 |
Why?
|
| Animals | 34 | 2022 | 14307 | 1.020 |
Why?
|
| Membrane Proteins | 5 | 2021 | 486 | 0.990 |
Why?
|
| Lectins, C-Type | 2 | 2021 | 35 | 0.970 |
Why?
|
| Diaphragm | 2 | 2022 | 10 | 0.960 |
Why?
|
| Viral Envelope Proteins | 2 | 2015 | 77 | 0.960 |
Why?
|
| Lysine | 2 | 2016 | 104 | 0.930 |
Why?
|
| Virion | 4 | 2014 | 67 | 0.880 |
Why?
|
| Actins | 10 | 2016 | 142 | 0.870 |
Why?
|
| Mitochondria | 2 | 2018 | 454 | 0.870 |
Why?
|
| Cytosine Deaminase | 3 | 2014 | 6 | 0.860 |
Why?
|
| Aortic Valve Stenosis | 1 | 2022 | 23 | 0.850 |
Why?
|
| Transcription Factor RelA | 2 | 2021 | 37 | 0.840 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2021 | 81 | 0.840 |
Why?
|
| Interleukin-1beta | 3 | 2018 | 66 | 0.840 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2021 | 15 | 0.820 |
Why?
|
| Mice, Inbred C57BL | 9 | 2022 | 1530 | 0.810 |
Why?
|
| Receptors, Calcitriol | 1 | 2021 | 59 | 0.780 |
Why?
|
| Disease Models, Animal | 8 | 2021 | 1300 | 0.780 |
Why?
|
| Glomerular Filtration Rate | 3 | 2016 | 137 | 0.770 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2021 | 54 | 0.770 |
Why?
|
| NF-kappa B | 4 | 2021 | 306 | 0.770 |
Why?
|
| Transfection | 9 | 2016 | 496 | 0.760 |
Why?
|
| Middle Aged | 17 | 2021 | 9642 | 0.750 |
Why?
|
| Autophagy | 1 | 2021 | 111 | 0.750 |
Why?
|
| Connective Tissue Growth Factor | 6 | 2012 | 18 | 0.750 |
Why?
|
| Muscle Weakness | 1 | 2019 | 7 | 0.740 |
Why?
|
| RNA-Binding Proteins | 1 | 2021 | 145 | 0.730 |
Why?
|
| Gene Products, vif | 5 | 2006 | 6 | 0.730 |
Why?
|
| China | 6 | 2020 | 178 | 0.720 |
Why?
|
| Albuminuria | 3 | 2015 | 76 | 0.710 |
Why?
|
| Disease Progression | 4 | 2016 | 580 | 0.700 |
Why?
|
| Receptors, Calcium-Sensing | 1 | 2019 | 14 | 0.690 |
Why?
|
| Virus Replication | 7 | 2014 | 261 | 0.690 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2021 | 200 | 0.680 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 10 | 2012 | 605 | 0.670 |
Why?
|
| Down-Regulation | 6 | 2021 | 420 | 0.670 |
Why?
|
| Female | 23 | 2022 | 19873 | 0.670 |
Why?
|
| Coronary Artery Disease | 1 | 2020 | 147 | 0.660 |
Why?
|
| Glomerulonephritis, IGA | 1 | 2018 | 1 | 0.650 |
Why?
|
| Mice, Knockout | 7 | 2021 | 897 | 0.650 |
Why?
|
| Collagen | 1 | 2019 | 162 | 0.650 |
Why?
|
| Aorta | 2 | 2016 | 161 | 0.630 |
Why?
|
| Thioredoxins | 1 | 2018 | 43 | 0.630 |
Why?
|
| Nephrectomy | 3 | 2020 | 23 | 0.630 |
Why?
|
| Adult | 16 | 2021 | 11034 | 0.630 |
Why?
|
| Ureteral Obstruction | 4 | 2021 | 17 | 0.630 |
Why?
|
| Mesangial Cells | 1 | 2017 | 9 | 0.630 |
Why?
|
| Multiprotein Complexes | 2 | 2015 | 53 | 0.620 |
Why?
|
| Rats | 9 | 2021 | 3261 | 0.610 |
Why?
|
| Kidney Glomerulus | 2 | 2021 | 80 | 0.610 |
Why?
|
| Ubiquitin | 2 | 2016 | 76 | 0.610 |
Why?
|
| Chemokine CCL2 | 1 | 2018 | 82 | 0.590 |
Why?
|
| Extracellular Matrix | 1 | 2017 | 111 | 0.590 |
Why?
|
| Health Benefit Plans, Employee | 1 | 2016 | 3 | 0.580 |
Why?
|
| Renal Replacement Therapy | 1 | 2016 | 8 | 0.570 |
Why?
|
| ADP-Ribosylation Factor 1 | 1 | 2015 | 1 | 0.560 |
Why?
|
| Angiotensin II | 3 | 2006 | 92 | 0.560 |
Why?
|
| Gene Expression | 6 | 2012 | 639 | 0.560 |
Why?
|
| Cost of Illness | 1 | 2016 | 79 | 0.560 |
Why?
|
| Receptors, Cell Surface | 2 | 2021 | 135 | 0.560 |
Why?
|
| Health Care Costs | 1 | 2016 | 69 | 0.550 |
Why?
|
| Reactive Oxygen Species | 1 | 2018 | 416 | 0.540 |
Why?
|
| Apolipoproteins E | 2 | 2013 | 129 | 0.530 |
Why?
|
| Population Surveillance | 2 | 2016 | 231 | 0.530 |
Why?
|
| Insurance Coverage | 1 | 2016 | 99 | 0.530 |
Why?
|
| Endothelial Cells | 2 | 2016 | 296 | 0.530 |
Why?
|
| Atherosclerosis | 2 | 2013 | 131 | 0.530 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2016 | 162 | 0.520 |
Why?
|
| Serum Albumin | 1 | 2015 | 49 | 0.520 |
Why?
|
| Neoplasm Proteins | 1 | 2016 | 203 | 0.510 |
Why?
|
| Adhesins, Bacterial | 1 | 2014 | 18 | 0.510 |
Why?
|
| Glucose | 1 | 2016 | 217 | 0.500 |
Why?
|
| Gene Expression Regulation | 6 | 2021 | 968 | 0.500 |
Why?
|
| Endopeptidases | 1 | 2014 | 58 | 0.500 |
Why?
|
| Hyperuricemia | 1 | 2014 | 10 | 0.490 |
Why?
|
| Aged | 11 | 2021 | 6448 | 0.490 |
Why?
|
| Proteinuria | 4 | 2020 | 48 | 0.490 |
Why?
|
| Nephritis | 3 | 2019 | 6 | 0.490 |
Why?
|
| Cell Membrane | 2 | 2014 | 360 | 0.490 |
Why?
|
| Vagina | 1 | 2014 | 81 | 0.490 |
Why?
|
| Sterol Regulatory Element Binding Proteins | 1 | 2013 | 3 | 0.480 |
Why?
|
| Sterol Regulatory Element Binding Protein 2 | 1 | 2013 | 5 | 0.480 |
Why?
|
| RNA Interference | 5 | 2021 | 225 | 0.480 |
Why?
|
| Foam Cells | 1 | 2013 | 13 | 0.480 |
Why?
|
| Retinoblastoma Protein | 1 | 2013 | 27 | 0.470 |
Why?
|
| Aortic Diseases | 1 | 2013 | 26 | 0.470 |
Why?
|
| Monocytes | 2 | 2013 | 258 | 0.470 |
Why?
|
| Risk Assessment | 1 | 2016 | 727 | 0.470 |
Why?
|
| Pyridones | 1 | 2013 | 40 | 0.470 |
Why?
|
| Cordyceps | 1 | 2013 | 3 | 0.470 |
Why?
|
| Smad Proteins | 1 | 2013 | 12 | 0.470 |
Why?
|
| GB virus C | 1 | 2013 | 1 | 0.460 |
Why?
|
| Dexamethasone | 1 | 2013 | 43 | 0.450 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2013 | 112 | 0.450 |
Why?
|
| Base Sequence | 6 | 2021 | 932 | 0.450 |
Why?
|
| RNA, Small Interfering | 2 | 2021 | 391 | 0.440 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2013 | 127 | 0.440 |
Why?
|
| Fibronectins | 4 | 2017 | 65 | 0.440 |
Why?
|
| Case-Control Studies | 3 | 2021 | 1056 | 0.430 |
Why?
|
| Lysosomes | 3 | 2020 | 80 | 0.430 |
Why?
|
| Prognosis | 4 | 2020 | 707 | 0.420 |
Why?
|
| Lipids | 1 | 2013 | 222 | 0.410 |
Why?
|
| Polyubiquitin | 1 | 2011 | 6 | 0.400 |
Why?
|
| Microscopy, Confocal | 4 | 2015 | 210 | 0.400 |
Why?
|
| Hemagglutinins | 1 | 2011 | 8 | 0.400 |
Why?
|
| Cullin Proteins | 3 | 2005 | 11 | 0.400 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2021 | 1534 | 0.400 |
Why?
|
| Mesoderm | 4 | 2007 | 70 | 0.400 |
Why?
|
| Blotting, Western | 7 | 2015 | 834 | 0.390 |
Why?
|
| Rats, Wistar | 3 | 2019 | 202 | 0.390 |
Why?
|
| Myocardium | 1 | 2013 | 224 | 0.390 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2010 | 17 | 0.390 |
Why?
|
| Anti-HIV Agents | 1 | 2014 | 394 | 0.380 |
Why?
|
| Plant Extracts | 1 | 2013 | 250 | 0.370 |
Why?
|
| Ubiquitination | 1 | 2010 | 54 | 0.360 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2010 | 88 | 0.360 |
Why?
|
| Heart | 1 | 2011 | 178 | 0.360 |
Why?
|
| Glycine | 2 | 2019 | 44 | 0.350 |
Why?
|
| Isoquinolines | 2 | 2019 | 40 | 0.350 |
Why?
|
| Anemia | 2 | 2019 | 45 | 0.350 |
Why?
|
| Hemoglobins | 2 | 2019 | 101 | 0.350 |
Why?
|
| Fluorescent Antibody Technique | 3 | 2015 | 185 | 0.340 |
Why?
|
| DNA Primers | 4 | 2013 | 269 | 0.340 |
Why?
|
| Gene Expression Profiling | 1 | 2012 | 600 | 0.330 |
Why?
|
| Simian immunodeficiency virus | 2 | 2010 | 56 | 0.330 |
Why?
|
| Antihypertensive Agents | 1 | 2011 | 284 | 0.320 |
Why?
|
| Cell Transdifferentiation | 1 | 2007 | 8 | 0.320 |
Why?
|
| Aged, 80 and over | 4 | 2020 | 2333 | 0.300 |
Why?
|
| Proteins | 3 | 2004 | 352 | 0.300 |
Why?
|
| Gene Products, gag | 4 | 2004 | 12 | 0.300 |
Why?
|
| Prevalence | 3 | 2016 | 1425 | 0.290 |
Why?
|
| Ultrasonography | 3 | 2022 | 115 | 0.290 |
Why?
|
| Cadherins | 4 | 2013 | 82 | 0.280 |
Why?
|
| Random Allocation | 2 | 2021 | 139 | 0.280 |
Why?
|
| Cross-Sectional Studies | 3 | 2019 | 2561 | 0.260 |
Why?
|
| Age Distribution | 2 | 2016 | 223 | 0.260 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2005 | 69 | 0.260 |
Why?
|
| Virus Release | 2 | 2015 | 7 | 0.260 |
Why?
|
| Risk Factors | 3 | 2020 | 3414 | 0.250 |
Why?
|
| Matrix Metalloproteinase 9 | 2 | 2017 | 88 | 0.250 |
Why?
|
| Hela Cells | 3 | 2015 | 344 | 0.250 |
Why?
|
| Leupeptins | 1 | 2004 | 11 | 0.250 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2016 | 117 | 0.250 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2004 | 21 | 0.240 |
Why?
|
| Cell Proliferation | 2 | 2021 | 1149 | 0.240 |
Why?
|
| Antiviral Agents | 1 | 2005 | 148 | 0.240 |
Why?
|
| Nucleoside Deaminases | 5 | 2007 | 7 | 0.240 |
Why?
|
| Hot Temperature | 2 | 2014 | 120 | 0.240 |
Why?
|
| Up-Regulation | 2 | 2017 | 490 | 0.240 |
Why?
|
| Calcium-Binding Proteins | 2 | 2016 | 72 | 0.240 |
Why?
|
| Phosphorylation | 2 | 2019 | 878 | 0.230 |
Why?
|
| Incidence | 2 | 2016 | 882 | 0.230 |
Why?
|
| Hematinics | 2 | 2019 | 6 | 0.230 |
Why?
|
| Young Adult | 4 | 2021 | 4012 | 0.220 |
Why?
|
| HIV Infections | 5 | 2018 | 2207 | 0.220 |
Why?
|
| Protein Transport | 2 | 2014 | 286 | 0.220 |
Why?
|
| Retrospective Studies | 2 | 2020 | 1961 | 0.220 |
Why?
|
| Area Under Curve | 2 | 2014 | 91 | 0.220 |
Why?
|
| ROC Curve | 2 | 2014 | 138 | 0.210 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2022 | 33 | 0.210 |
Why?
|
| Aortic Valve | 1 | 2022 | 25 | 0.210 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 2013 | 53 | 0.210 |
Why?
|
| Ergocalciferols | 1 | 2021 | 6 | 0.210 |
Why?
|
| Mice, Inbred NOD | 1 | 2021 | 43 | 0.210 |
Why?
|
| Bone Density Conservation Agents | 1 | 2021 | 22 | 0.210 |
Why?
|
| Phosphorus | 1 | 2022 | 64 | 0.210 |
Why?
|
| Caspase 8 | 1 | 2021 | 31 | 0.210 |
Why?
|
| Chemokines | 1 | 2022 | 89 | 0.210 |
Why?
|
| Necrosis | 1 | 2021 | 45 | 0.210 |
Why?
|
| Tight Junctions | 1 | 2021 | 24 | 0.200 |
Why?
|
| Rats, Inbred SHR | 2 | 2011 | 31 | 0.200 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2013 | 184 | 0.200 |
Why?
|
| 3' Untranslated Regions | 1 | 2021 | 67 | 0.200 |
Why?
|
| Apoptosis | 3 | 2022 | 1317 | 0.200 |
Why?
|
| Cyclin B1 | 1 | 2021 | 16 | 0.200 |
Why?
|
| CDC2 Protein Kinase | 1 | 2021 | 17 | 0.200 |
Why?
|
| G2 Phase | 1 | 2021 | 25 | 0.200 |
Why?
|
| Repressor Proteins | 5 | 2007 | 226 | 0.200 |
Why?
|
| Cell Division | 2 | 2021 | 296 | 0.200 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2021 | 72 | 0.200 |
Why?
|
| Ligands | 1 | 2022 | 317 | 0.200 |
Why?
|
| Muscle, Smooth | 3 | 2012 | 51 | 0.200 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2013 | 180 | 0.200 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2021 | 49 | 0.190 |
Why?
|
| Ischemia | 1 | 2021 | 45 | 0.190 |
Why?
|
| Caspase 3 | 1 | 2021 | 194 | 0.190 |
Why?
|
| Tissue Distribution | 1 | 2021 | 197 | 0.190 |
Why?
|
| Albumins | 1 | 2020 | 24 | 0.190 |
Why?
|
| Erythrocytes | 1 | 2021 | 107 | 0.190 |
Why?
|
| Cell Death | 1 | 2021 | 260 | 0.190 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2021 | 69 | 0.190 |
Why?
|
| Cholesterol | 3 | 2019 | 194 | 0.190 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2021 | 139 | 0.190 |
Why?
|
| Hiccup | 1 | 2019 | 1 | 0.190 |
Why?
|
| Total Lung Capacity | 1 | 2019 | 4 | 0.190 |
Why?
|
| Dyspnea | 1 | 2019 | 15 | 0.180 |
Why?
|
| Epoetin Alfa | 1 | 2019 | 2 | 0.180 |
Why?
|
| Peptides | 2 | 2021 | 308 | 0.180 |
Why?
|
| DNA Damage | 1 | 2022 | 341 | 0.180 |
Why?
|
| Plasmids | 2 | 2013 | 233 | 0.180 |
Why?
|
| Sensitivity and Specificity | 3 | 2012 | 555 | 0.180 |
Why?
|
| Smad2 Protein | 1 | 2019 | 9 | 0.180 |
Why?
|
| Cyclohexylamines | 1 | 2019 | 12 | 0.180 |
Why?
|
| Fatigue | 1 | 2019 | 79 | 0.180 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2016 | 984 | 0.180 |
Why?
|
| Adenine | 1 | 2019 | 43 | 0.170 |
Why?
|
| Insulin Resistance | 1 | 2021 | 177 | 0.170 |
Why?
|
| Cell Hypoxia | 1 | 2018 | 55 | 0.170 |
Why?
|
| Protein Structure, Tertiary | 2 | 2013 | 383 | 0.170 |
Why?
|
| Benzamides | 1 | 2019 | 76 | 0.170 |
Why?
|
| Porphyromonas gingivalis | 1 | 2018 | 23 | 0.170 |
Why?
|
| Mice, Inbred BALB C | 2 | 2019 | 649 | 0.160 |
Why?
|
| Disease Transmission, Infectious | 1 | 2018 | 29 | 0.160 |
Why?
|
| Virus Internalization | 1 | 2018 | 27 | 0.160 |
Why?
|
| Cell Communication | 1 | 2018 | 93 | 0.160 |
Why?
|
| Organophosphorus Compounds | 1 | 2018 | 36 | 0.160 |
Why?
|
| Immunohistochemistry | 3 | 2011 | 859 | 0.160 |
Why?
|
| Cytokines | 1 | 2021 | 569 | 0.160 |
Why?
|
| Piperidines | 1 | 2018 | 76 | 0.160 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 608 | 0.160 |
Why?
|
| Collagen Type I | 1 | 2017 | 27 | 0.160 |
Why?
|
| Serum Albumin, Bovine | 1 | 2018 | 49 | 0.160 |
Why?
|
| Enzyme Activation | 2 | 2016 | 423 | 0.160 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2017 | 47 | 0.160 |
Why?
|
| Gene Silencing | 1 | 2018 | 143 | 0.150 |
Why?
|
| Receptors, Pattern Recognition | 1 | 2016 | 9 | 0.150 |
Why?
|
| Phenotype | 2 | 2016 | 650 | 0.150 |
Why?
|
| Follow-Up Studies | 2 | 2016 | 964 | 0.140 |
Why?
|
| Data Interpretation, Statistical | 1 | 2017 | 111 | 0.140 |
Why?
|
| HIV Envelope Protein gp120 | 2 | 2009 | 54 | 0.140 |
Why?
|
| Cause of Death | 1 | 2016 | 154 | 0.140 |
Why?
|
| Cohort Studies | 1 | 2020 | 1422 | 0.140 |
Why?
|
| Lentiviruses, Primate | 2 | 2005 | 2 | 0.140 |
Why?
|
| Coculture Techniques | 2 | 2013 | 96 | 0.140 |
Why?
|
| Ubiquitin-Protein Ligase Complexes | 2 | 2005 | 8 | 0.140 |
Why?
|
| Forecasting | 1 | 2016 | 124 | 0.140 |
Why?
|
| Interleukin-18 | 1 | 2015 | 13 | 0.130 |
Why?
|
| Recombinant Proteins | 2 | 2007 | 485 | 0.130 |
Why?
|
| Hospital Mortality | 1 | 2016 | 183 | 0.130 |
Why?
|
| Cathepsin B | 1 | 2015 | 29 | 0.130 |
Why?
|
| RNA, Viral | 2 | 2014 | 287 | 0.130 |
Why?
|
| Hypertrophy | 2 | 2005 | 31 | 0.130 |
Why?
|
| Hep G2 Cells | 1 | 2015 | 52 | 0.130 |
Why?
|
| Streptococcus | 1 | 2014 | 13 | 0.130 |
Why?
|
| Enzyme Stability | 1 | 2014 | 30 | 0.130 |
Why?
|
| Cell Cycle | 2 | 2006 | 309 | 0.130 |
Why?
|
| Antioxidants | 1 | 2018 | 386 | 0.130 |
Why?
|
| Point Mutation | 1 | 2014 | 88 | 0.130 |
Why?
|
| Endosomes | 1 | 2014 | 34 | 0.120 |
Why?
|
| Cell Movement | 1 | 2018 | 545 | 0.120 |
Why?
|
| Lipid Metabolism | 1 | 2015 | 109 | 0.120 |
Why?
|
| Registries | 1 | 2016 | 330 | 0.120 |
Why?
|
| Ultracentrifugation | 1 | 2013 | 16 | 0.120 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 2013 | 27 | 0.120 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2013 | 34 | 0.120 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2013 | 9 | 0.120 |
Why?
|
| Golgi Apparatus | 1 | 2013 | 25 | 0.120 |
Why?
|
| Eukaryotic Initiation Factors | 1 | 2013 | 13 | 0.120 |
Why?
|
| Limit of Detection | 1 | 2013 | 56 | 0.120 |
Why?
|
| Sex Distribution | 1 | 2014 | 212 | 0.120 |
Why?
|
| Cell Culture Techniques | 1 | 2014 | 136 | 0.120 |
Why?
|
| S Phase | 1 | 2013 | 36 | 0.120 |
Why?
|
| Age Factors | 1 | 2016 | 1007 | 0.120 |
Why?
|
| Microscopy, Fluorescence | 1 | 2014 | 240 | 0.120 |
Why?
|
| Serum Amyloid A Protein | 1 | 2013 | 14 | 0.120 |
Why?
|
| Endothelium | 1 | 2013 | 31 | 0.110 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2013 | 53 | 0.110 |
Why?
|
| Endoplasmic Reticulum | 1 | 2013 | 101 | 0.110 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 424 | 0.110 |
Why?
|
| Glycosylation | 1 | 2013 | 92 | 0.110 |
Why?
|
| Triglycerides | 1 | 2013 | 129 | 0.110 |
Why?
|
| Blood Urea Nitrogen | 1 | 2012 | 3 | 0.110 |
Why?
|
| Phosphoproteins | 1 | 2013 | 154 | 0.110 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2013 | 185 | 0.110 |
Why?
|
| Odds Ratio | 1 | 2014 | 517 | 0.110 |
Why?
|
| Multivariate Analysis | 1 | 2014 | 570 | 0.110 |
Why?
|
| Health Surveys | 1 | 2014 | 358 | 0.110 |
Why?
|
| Microarray Analysis | 1 | 2012 | 61 | 0.110 |
Why?
|
| Biopsy | 1 | 2012 | 151 | 0.110 |
Why?
|
| Life Style | 1 | 2014 | 288 | 0.110 |
Why?
|
| Cell Adhesion | 1 | 2013 | 209 | 0.110 |
Why?
|
| Peptide Fragments | 2 | 2006 | 298 | 0.110 |
Why?
|
| Aging | 1 | 2016 | 639 | 0.100 |
Why?
|
| Actinin | 1 | 2011 | 7 | 0.100 |
Why?
|
| Sialoglycoproteins | 1 | 2011 | 10 | 0.100 |
Why?
|
| Molecular Sequence Data | 6 | 2011 | 1490 | 0.100 |
Why?
|
| Jurkat Cells | 3 | 2009 | 72 | 0.100 |
Why?
|
| Desmin | 1 | 2011 | 2 | 0.100 |
Why?
|
| Viral Load | 1 | 2013 | 300 | 0.100 |
Why?
|
| Cell Cycle Proteins | 1 | 2013 | 220 | 0.100 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2013 | 137 | 0.100 |
Why?
|
| Rats, Inbred WKY | 1 | 2011 | 23 | 0.100 |
Why?
|
| Microfilament Proteins | 1 | 2011 | 64 | 0.100 |
Why?
|
| Residence Characteristics | 1 | 2014 | 301 | 0.100 |
Why?
|
| Creatinine | 1 | 2011 | 101 | 0.100 |
Why?
|
| Logistic Models | 1 | 2014 | 894 | 0.100 |
Why?
|
| Time Factors | 2 | 2016 | 1681 | 0.100 |
Why?
|
| Microscopy, Electron | 1 | 2011 | 186 | 0.100 |
Why?
|
| Echocardiography | 1 | 2011 | 144 | 0.100 |
Why?
|
| Echocardiography, Doppler | 1 | 2010 | 39 | 0.100 |
Why?
|
| Prostate | 1 | 2011 | 136 | 0.100 |
Why?
|
| Cytoskeletal Proteins | 1 | 2011 | 97 | 0.090 |
Why?
|
| Socioeconomic Factors | 1 | 2014 | 1003 | 0.090 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2011 | 286 | 0.090 |
Why?
|
| Ventricular Function, Left | 1 | 2010 | 104 | 0.090 |
Why?
|
| Cell Differentiation | 1 | 2013 | 562 | 0.090 |
Why?
|
| Pilot Projects | 1 | 2012 | 628 | 0.090 |
Why?
|
| Hyperkalemia | 2 | 2019 | 13 | 0.090 |
Why?
|
| Recombination, Genetic | 2 | 2007 | 90 | 0.090 |
Why?
|
| Cisplatin | 2 | 2022 | 70 | 0.090 |
Why?
|
| Arrestins | 1 | 2009 | 26 | 0.090 |
Why?
|
| COS Cells | 3 | 2004 | 62 | 0.090 |
Why?
|
| Reproducibility of Results | 1 | 2012 | 901 | 0.090 |
Why?
|
| Double-Blind Method | 2 | 2019 | 269 | 0.080 |
Why?
|
| Morphine | 1 | 2009 | 80 | 0.080 |
Why?
|
| Lymphocytes | 1 | 2009 | 116 | 0.080 |
Why?
|
| Mass Screening | 1 | 2012 | 427 | 0.080 |
Why?
|
| Colorectal Neoplasms | 1 | 2013 | 413 | 0.080 |
Why?
|
| RNA, Small Cytoplasmic | 1 | 2007 | 3 | 0.080 |
Why?
|
| Signal Recognition Particle | 1 | 2007 | 6 | 0.080 |
Why?
|
| Integrases | 1 | 2007 | 27 | 0.080 |
Why?
|
| Cell Line, Transformed | 1 | 2007 | 87 | 0.080 |
Why?
|
| HIV Integrase | 1 | 2007 | 18 | 0.080 |
Why?
|
| Blood Pressure | 1 | 2011 | 613 | 0.080 |
Why?
|
| Virus Integration | 1 | 2007 | 49 | 0.070 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2006 | 38 | 0.070 |
Why?
|
| Keratins | 1 | 2006 | 25 | 0.070 |
Why?
|
| Vimentin | 1 | 2006 | 32 | 0.070 |
Why?
|
| T-Lymphocytes | 2 | 2006 | 341 | 0.070 |
Why?
|
| Adolescent | 1 | 2016 | 5035 | 0.070 |
Why?
|
| Amino Acid Sequence | 5 | 2011 | 1124 | 0.070 |
Why?
|
| Reference Values | 1 | 2005 | 204 | 0.070 |
Why?
|
| Genetic Vectors | 2 | 2002 | 154 | 0.070 |
Why?
|
| Nucleocapsid | 1 | 2004 | 12 | 0.060 |
Why?
|
| Flow Cytometry | 2 | 2003 | 392 | 0.060 |
Why?
|
| Gene Deletion | 1 | 2005 | 156 | 0.060 |
Why?
|
| Sequence Deletion | 2 | 2008 | 87 | 0.060 |
Why?
|
| Mitogens | 1 | 2003 | 10 | 0.060 |
Why?
|
| Cysteine Endopeptidases | 1 | 2004 | 57 | 0.060 |
Why?
|
| Multienzyme Complexes | 1 | 2004 | 63 | 0.060 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2003 | 138 | 0.060 |
Why?
|
| Cell Separation | 1 | 2003 | 91 | 0.060 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2004 | 109 | 0.060 |
Why?
|
| Gene Products, env | 1 | 2002 | 23 | 0.060 |
Why?
|
| Sindbis Virus | 1 | 2002 | 14 | 0.060 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2022 | 49 | 0.050 |
Why?
|
| Genomic Instability | 1 | 2022 | 34 | 0.050 |
Why?
|
| Telomere | 1 | 2022 | 51 | 0.050 |
Why?
|
| Protein Binding | 2 | 2008 | 913 | 0.050 |
Why?
|
| Sulfones | 1 | 2021 | 40 | 0.050 |
Why?
|
| Nitriles | 1 | 2021 | 66 | 0.050 |
Why?
|
| Ecosystem | 1 | 2022 | 119 | 0.050 |
Why?
|
| Mice, Transgenic | 2 | 2016 | 608 | 0.050 |
Why?
|
| Genomics | 1 | 2022 | 201 | 0.050 |
Why?
|
| Autocrine Communication | 1 | 2020 | 10 | 0.050 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2002 | 123 | 0.050 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2021 | 143 | 0.050 |
Why?
|
| Paracrine Communication | 1 | 2020 | 14 | 0.050 |
Why?
|
| Interferon Regulatory Factor-1 | 1 | 2020 | 6 | 0.050 |
Why?
|
| Disease Outbreaks | 1 | 2002 | 155 | 0.050 |
Why?
|
| Vaccines, DNA | 1 | 2000 | 23 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 2 | 2016 | 484 | 0.050 |
Why?
|
| AIDS Vaccines | 1 | 2000 | 30 | 0.050 |
Why?
|
| Capsid | 1 | 2000 | 51 | 0.050 |
Why?
|
| Doxorubicin | 1 | 2020 | 80 | 0.050 |
Why?
|
| Capsid Proteins | 1 | 2000 | 60 | 0.050 |
Why?
|
| Neoplasms | 1 | 2009 | 1033 | 0.050 |
Why?
|
| Genetic Variation | 1 | 2002 | 328 | 0.040 |
Why?
|
| Acidosis | 1 | 2019 | 49 | 0.040 |
Why?
|
| Viral Proteins | 1 | 2000 | 172 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2022 | 1353 | 0.040 |
Why?
|
| Analysis of Variance | 1 | 2019 | 528 | 0.040 |
Why?
|
| Mutation | 3 | 2007 | 1023 | 0.040 |
Why?
|
| Interferon-gamma | 2 | 2013 | 235 | 0.040 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2016 | 21 | 0.040 |
Why?
|
| Adoptive Transfer | 1 | 2016 | 48 | 0.040 |
Why?
|
| Models, Biological | 1 | 2020 | 642 | 0.040 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2016 | 91 | 0.040 |
Why?
|
| Models, Theoretical | 1 | 2018 | 210 | 0.040 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2016 | 58 | 0.040 |
Why?
|
| Antigens, CD | 1 | 2016 | 116 | 0.040 |
Why?
|
| Cell Line, Tumor | 2 | 2013 | 2128 | 0.030 |
Why?
|
| Binding Sites | 1 | 2016 | 597 | 0.030 |
Why?
|
| DNA, Viral | 2 | 2007 | 295 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 161 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2013 | 269 | 0.030 |
Why?
|
| Hypertension | 1 | 2019 | 770 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2013 | 211 | 0.030 |
Why?
|
| U937 Cells | 1 | 2011 | 27 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2011 | 195 | 0.030 |
Why?
|
| Culture Media, Conditioned | 1 | 2011 | 44 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2013 | 245 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2011 | 255 | 0.020 |
Why?
|
| Host-Pathogen Interactions | 1 | 2011 | 179 | 0.020 |
Why?
|
| Transcription Factors | 2 | 2005 | 653 | 0.020 |
Why?
|
| Receptors, Opioid, mu | 1 | 2009 | 47 | 0.020 |
Why?
|
| Genes, gag | 1 | 2008 | 5 | 0.020 |
Why?
|
| Leucine Zippers | 1 | 2007 | 5 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2013 | 781 | 0.020 |
Why?
|
| Pancreas | 1 | 2007 | 32 | 0.020 |
Why?
|
| Analgesics, Opioid | 1 | 2009 | 176 | 0.020 |
Why?
|
| Reverse Transcription | 1 | 2007 | 16 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2007 | 132 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2007 | 152 | 0.020 |
Why?
|
| vpr Gene Products, Human Immunodeficiency Virus | 1 | 2006 | 7 | 0.020 |
Why?
|
| Gene Products, vpr | 1 | 2006 | 5 | 0.020 |
Why?
|
| Alleles | 1 | 2007 | 284 | 0.020 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2006 | 108 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2005 | 85 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2005 | 126 | 0.020 |
Why?
|
| Fusion Proteins, gag-pol | 1 | 2004 | 3 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2005 | 186 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2005 | 257 | 0.020 |
Why?
|
| Prostatic Neoplasms | 1 | 2011 | 794 | 0.010 |
Why?
|
| Cytopathogenic Effect, Viral | 1 | 2002 | 13 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2002 | 135 | 0.010 |
Why?
|
| Phylogeny | 1 | 2005 | 612 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2002 | 249 | 0.010 |
Why?
|
| Intracellular Fluid | 1 | 2000 | 26 | 0.010 |
Why?
|
| Vaccinia virus | 1 | 2000 | 10 | 0.010 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2000 | 19 | 0.010 |
Why?
|
| Interleukin-4 | 1 | 2000 | 69 | 0.010 |
Why?
|
| Staining and Labeling | 1 | 2000 | 100 | 0.010 |
Why?
|
| Ovary | 1 | 2000 | 101 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2000 | 445 | 0.010 |
Why?
|